Two Differently Regulated Nuclear Factor κ B Activation Pathways Triggered by the Cytoplasmic Tail of CD40

CD40 signaling modulates the immune response at least in part by activation of nuclear factor κ B (NFκ B). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NFκ B. Although four members of the tumor necrosis factor receptor...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 96; no. 4; pp. 1234 - 1239
Main Authors Tsukamoto, Nobuo, Kobayashi, Norihiko, Azuma, Sakura, Yamamoto, Tadashi, Inoue, Jun-ichiro
Format Journal Article
LanguageEnglish
Published National Academy of Sciences of the United States of America 16.02.1999
National Acad Sciences
The National Academy of Sciences
Subjects
Online AccessGet full text

Cover

Loading…
Abstract CD40 signaling modulates the immune response at least in part by activation of nuclear factor κ B (NFκ B). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NFκ B. Although four members of the tumor necrosis factor receptor-associated factor (TRAF) family, including TRAF2, TRAF3, TRAF5, and TRAF6, bind to the CD40 cyt, how each TRAF protein contributes to the NFκ B activation by CD40 is not clear. Here we report that TRAF2, TRAF3, and TRAF5 bind cyt-C, whereas TRAF6 binds cyt-N. cyt-N is conserved poorly between human and mouse CD40, while cyt-C is highly conserved. However, single aa substitution of Glu-235 in cyt-N of human CD40 with Ala abolishes the binding of TRAF6 to cyt-N and NFκ B activation by cyt-N. Conservation of this Glu between mouse and human CD40 strongly suggests that TRAF6 could link cyt-N to signals essential for CD40-mediated immune response. Furthermore, NFκ B activation by cyt-C is inhibited by a kinase-negative form of NFκ B-inducing kinase more efficiently than that by cyt-N, consistent with the result that NFκ B activation by TRAF2 and TRAF5 is inhibited by a kinase-negative form of NFκ B-inducing kinase more efficiently than that by TRAF6. These results indicate that NFκ B activating signals emanating from cyt-N and cyt-C are mediated by the different members of the TRAF family and could be regulated in a distinct manner.
AbstractList CD40 signaling modulates the immune response at least in part by activation of nuclear factor κB (NFκB). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NFκB. Although four members of the tumor necrosis factor receptor-associated factor (TRAF) family, including TRAF2, TRAF3, TRAF5, and TRAF6, bind to the CD40 cyt, how each TRAF protein contributes to the NFκB activation by CD40 is not clear. Here we report that TRAF2, TRAF3, and TRAF5 bind cyt-C, whereas TRAF6 binds cyt-N. cyt-N is conserved poorly between human and mouse CD40, while cyt-C is highly conserved. However, single aa substitution of Glu-235 in cyt-N of human CD40 with Ala abolishes the binding of TRAF6 to cyt-N and NFκB activation by cyt-N. Conservation of this Glu between mouse and human CD40 strongly suggests that TRAF6 could link cyt-N to signals essential for CD40-mediated immune response. Furthermore, NFκB activation by cyt-C is inhibited by a kinase-negative form of NFκB-inducing kinase more efficiently than that by cyt-N, consistent with the result that NFκB activation by TRAF2 and TRAF5 is inhibited by a kinase-negative form of NFκB-inducing kinase more efficiently than that by TRAF6. These results indicate that NFκB activating signals emanating from cyt-N and cyt-C are mediated by the different members of the TRAF family and could be regulated in a distinct manner. tumor necrosis factor receptor-associated factor nuclear factor κB-inducing kinase protein–protein interaction
CD40 signaling modulates the immune response at least in part by activation of nuclear factor Kappa B (NF Kappa B). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NF Kappa B. Although four members of the tumor necrosis factor receptor-associated factor (TRAF) family including TRAF2, TRAF3, TRAF5, and TRAF6, bind to the CD40 cyt, how each TRAF protein contributes to the NF Kappa B activation by CD40 is not clear. Here we report that TRAF2, TRAF3, and TRAF5 bind cyt-C, whereas TRAF6 binds cyt-N. cyt-N is conserved poorly between human and mouse CD40, while cyt-C is highly conserved. However, single aa substitution of Glu-235 in cyt-N of human CD40 with Ala abolishes the binding of TRAF6 to cyt-N and NF Kappa B activation by cyt-N. Conservation of this Glu between mouse and human CD40 strongly suggests that TRAF6 could link cyt-N to signals essential for CD40-mediated immune response. Furthermore, NF Kappa B activation by cyt-C is inhibited by a kinase-negative form of NF Kappa B-inducing kinase more efficiently than that by cyt-N, consistent with the result that NF Kappa B activation by TRAF2 and TRAF5 is inhibited by a kinase-negative form of NF Kappa B-inducing kinase more efficiently than that by TRAF6. These results indicate that NF Kappa B activating signals emanating from cyt-N and cyt-C are mediated by the different members of the TRAF family and could be regulated in a distinct manner.
CD40 signaling modulates the immune response at least in part by activation of nuclear factor κ B (NFκ B). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NFκ B. Although four members of the tumor necrosis factor receptor-associated factor (TRAF) family, including TRAF2, TRAF3, TRAF5, and TRAF6, bind to the CD40 cyt, how each TRAF protein contributes to the NFκ B activation by CD40 is not clear. Here we report that TRAF2, TRAF3, and TRAF5 bind cyt-C, whereas TRAF6 binds cyt-N. cyt-N is conserved poorly between human and mouse CD40, while cyt-C is highly conserved. However, single aa substitution of Glu-235 in cyt-N of human CD40 with Ala abolishes the binding of TRAF6 to cyt-N and NFκ B activation by cyt-N. Conservation of this Glu between mouse and human CD40 strongly suggests that TRAF6 could link cyt-N to signals essential for CD40-mediated immune response. Furthermore, NFκ B activation by cyt-C is inhibited by a kinase-negative form of NFκ B-inducing kinase more efficiently than that by cyt-N, consistent with the result that NFκ B activation by TRAF2 and TRAF5 is inhibited by a kinase-negative form of NFκ B-inducing kinase more efficiently than that by TRAF6. These results indicate that NFκ B activating signals emanating from cyt-N and cyt-C are mediated by the different members of the TRAF family and could be regulated in a distinct manner.
CD40 signaling modulates the immune response at least in part by activation of nuclear factor κB (NFκB). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NFκB. Although four members of the tumor necrosis factor receptor-associated factor (TRAF) family, including TRAF2, TRAF3, TRAF5, and TRAF6, bind to the CD40 cyt, how each TRAF protein contributes to the NFκB activation by CD40 is not clear. Here we report that TRAF2, TRAF3, and TRAF5 bind cyt-C, whereas TRAF6 binds cyt-N. cyt-N is conserved poorly between human and mouse CD40, while cyt-C is highly conserved. However, single aa substitution of Glu-235 in cyt-N of human CD40 with Ala abolishes the binding of TRAF6 to cyt-N and NFκB activation by cyt-N. Conservation of this Glu between mouse and human CD40 strongly suggests that TRAF6 could link cyt-N to signals essential for CD40-mediated immune response. Furthermore, NFκB activation by cyt-C is inhibited by a kinase-negative form of NFκB-inducing kinase more efficiently than that by cyt-N, consistent with the result that NFκB activation by TRAF2 and TRAF5 is inhibited by a kinase-negative form of NFκB-inducing kinase more efficiently than that by TRAF6. These results indicate that NFκB activating signals emanating from cyt-N and cyt-C are mediated by the different members of the TRAF family and could be regulated in a distinct manner.
CD40 signaling modulates the immune response at least in part by activation of nuclear factor κB (NFκB). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NFκB. Although four members of the tumor necrosis factor receptor-associated factor (TRAF) family, including TRAF2, TRAF3, TRAF5, and TRAF6, bind to the CD40 cyt, how each TRAF protein contributes to the NFκB activation by CD40 is not clear. Here we report that TRAF2, TRAF3, and TRAF5 bind cyt-C, whereas TRAF6 binds cyt-N. cyt-N is conserved poorly between human and mouse CD40, while cyt-C is highly conserved. However, single aa substitution of Glu-235 in cyt-N of human CD40 with Ala abolishes the binding of TRAF6 to cyt-N and NFκB activation by cyt-N. Conservation of this Glu between mouse and human CD40 strongly suggests that TRAF6 could link cyt-N to signals essential for CD40-mediated immune response. Furthermore, NFκB activation by cyt-C is inhibited by a kinase-negative form of NFκB-inducing kinase more efficiently than that by cyt-N, consistent with the result that NFκB activation by TRAF2 and TRAF5 is inhibited by a kinase-negative form of NFκB-inducing kinase more efficiently than that by TRAF6. These results indicate that NFκB activating signals emanating from cyt-N and cyt-C are mediated by the different members of the TRAF family and could be regulated in a distinct manner.
Author Tsukamoto, Nobuo
Kobayashi, Norihiko
Inoue, Jun-ichiro
Azuma, Sakura
Yamamoto, Tadashi
AuthorAffiliation Department of Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
AuthorAffiliation_xml – name: Department of Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
Author_xml – sequence: 1
  givenname: Nobuo
  surname: Tsukamoto
  fullname: Tsukamoto, Nobuo
– sequence: 2
  givenname: Norihiko
  surname: Kobayashi
  fullname: Kobayashi, Norihiko
– sequence: 3
  givenname: Sakura
  surname: Azuma
  fullname: Azuma, Sakura
– sequence: 4
  givenname: Tadashi
  surname: Yamamoto
  fullname: Yamamoto, Tadashi
– sequence: 5
  givenname: Jun-ichiro
  surname: Inoue
  fullname: Inoue, Jun-ichiro
BookMark eNp9kc1uEzEUhS1UVNLClgUSklfsJthjjx1LbEpKAakChMLacjx3EhdnHGxPy7waD9FnqkPaSCDByrLP-Xx_zgk66kMPCD2nZEqJZK-3vUlTJaZ8SmvGH6EJJYpWgityhCaE1LKa8Zo_QScpXRFCVDMjx-hYKVUucoK-L24CPnddBxH67Ef8FVaDNxla_GmwHkzEF8bmEPHtL_wWn9nsrk12ocdfTF7fmDHhRXSrVcFbvBxxXgOejzlsvUkbZ_HCOI9Dh-fnnDxFjzvjEzy7P0_Rt4t3i_mH6vLz-4_zs8vKMsVy1TaKcMsMlYpYQTprFVGsbmVLO5CCNCApo8sl1BYoSCs4dHVbC9Y2wGph2Sl6s_93Oyw30NoyWDReb6PbmDjqYJz-U-ndWq_CtaYN56Lgr-7xGH4MkLLeuGTBe9NDGJKmkgrBKC_G6d5oY0gpQncoQYnehaN34WglNNe7cArA_wKsy7-3Wdpw_t_YQ0O794caB113g_cZfuZifPk_Y9Ff7PWrVBI9GLiks4bdAQpTt5g
CitedBy_id crossref_primary_10_1002_pro_70004
crossref_primary_10_1128_JVI_02542_06
crossref_primary_10_4049_jimmunol_173_5_2913
crossref_primary_10_1074_jbc_M109889200
crossref_primary_10_4049_jimmunol_167_11_6388
crossref_primary_10_1111_j_1349_7006_2007_00389_x
crossref_primary_10_1083_jcb_201003087
crossref_primary_10_1016_j_gene_2005_05_016
crossref_primary_10_1089_ars_2007_1631
crossref_primary_10_3389_fimmu_2023_1214095
crossref_primary_10_1007_s00774_012_0353_5
crossref_primary_10_1016_j_clml_2012_01_006
crossref_primary_10_1111_j_1600_065X_2011_01055_x
crossref_primary_10_1038_s41417_018_0038_x
crossref_primary_10_2183_pjab_97_009
crossref_primary_10_4049_jimmunol_1302643
crossref_primary_10_1177_030089160208800502
crossref_primary_10_1152_ajprenal_00317_2004
crossref_primary_10_1091_mbc_e02_07_0378
crossref_primary_10_1038_sj_emboj_7600564
crossref_primary_10_1074_jbc_M300720200
crossref_primary_10_1080_10428190290033288
crossref_primary_10_4049_jimmunol_0900528
crossref_primary_10_1084_jem_20091293
crossref_primary_10_3892_ol_2018_9849
crossref_primary_10_1046_j_1365_2567_2000_00061_x
crossref_primary_10_1002__SICI_1521_4141_199912_29_12_3908__AID_IMMU3908_3_0_CO_2_E
crossref_primary_10_3389_fimmu_2019_00222
crossref_primary_10_1093_intimm_dxp013
crossref_primary_10_1016_j_molimm_2007_06_161
crossref_primary_10_1152_ajpheart_00750_2005
crossref_primary_10_1073_pnas_98_4_1751
crossref_primary_10_1096_fj_08_124545
crossref_primary_10_1016_S0898_6568_02_00083_9
crossref_primary_10_1074_jbc_M104994200
crossref_primary_10_1007_s10735_014_9575_2
crossref_primary_10_1128_JVI_77_2_1316_1328_2003
crossref_primary_10_1046_j_1365_2567_2001_01162_x
crossref_primary_10_1128_JVI_76_9_4567_4579_2002
crossref_primary_10_1002_eji_200737828
crossref_primary_10_1097_00062752_200307000_00004
crossref_primary_10_4049_jimmunol_1201646
crossref_primary_10_1074_jbc_274_52_37251
crossref_primary_10_1016_S1074_7613_00_80113_2
crossref_primary_10_1038_s41598_019_57293_y
crossref_primary_10_1074_jbc_275_13_9501
crossref_primary_10_1002_pro_4429
crossref_primary_10_1074_jbc_M310969200
crossref_primary_10_1038_cddis_2014_172
crossref_primary_10_1007_BF02256091
crossref_primary_10_1002_2211_5463_12211
crossref_primary_10_1074_jbc_M000531200
crossref_primary_10_1016_j_oraloncology_2006_12_008
crossref_primary_10_1074_jbc_274_42_30202
crossref_primary_10_1093_intimm_14_3_319
crossref_primary_10_1111_j_1365_2443_2010_01474_x
crossref_primary_10_1074_jbc_M109250200
crossref_primary_10_1038_ni792
crossref_primary_10_1097_00130832_200212000_00003
crossref_primary_10_1016_j_pharmthera_2020_107709
crossref_primary_10_3389_fcell_2020_624985
crossref_primary_10_1189_jlb_0313157
crossref_primary_10_1128_MCB_25_22_9806_9819_2005
crossref_primary_10_1073_pnas_052247099
crossref_primary_10_1016_S1074_7613_02_00394_1
crossref_primary_10_1074_jbc_274_32_22414
crossref_primary_10_1006_excr_1999_4733
crossref_primary_10_1074_jbc_M110_118877
crossref_primary_10_1002_eji_200526219
crossref_primary_10_1002_eji_201646294
crossref_primary_10_1006_mthe_2002_0693
crossref_primary_10_1016_j_molimm_2010_08_011
crossref_primary_10_1128_MCB_20_15_5503_5515_2000
crossref_primary_10_1161_01_CIR_0000083718_76889_D0
Cites_doi 10.1002/eji.1830200819
10.1016/0092-8674(95)90489-1
10.1128/MCB.16.12.7098
10.1126/science.8171316
10.1101/gad.10.8.963
10.1038/385540a0
10.1038/383443a0
10.1073/pnas.95.7.3537
10.1073/pnas.93.18.9437
10.1016/0092-8674(84)90472-0
10.1111/j.1600-065X.1994.tb00845.x
10.1016/0014-5793(94)01406-Q
10.1084/jem.182.5.1557
10.4049/jimmunol.155.12.5527
10.4049/jimmunol.148.2.620
10.1073/pnas.93.18.9699
10.1038/30996
10.1038/31002
10.1084/jem.169.6.2043
10.1038/357080a0
10.4049/jimmunol.153.10.4357
10.1084/jem.179.2.673
10.1074/jbc.271.46.28745
10.1084/jem.179.6.1923
10.1126/science.7533327
10.1002/j.1460-2075.1989.tb03521.x
10.1016/S0021-9258(18)43772-6
10.1021/bi981067q
10.1073/pnas.94.18.9792
10.1002/eji.1830221112
10.1073/pnas.89.12.5206
10.1073/pnas.82.2.488
10.1038/30989
10.1016/0092-8674(94)90532-0
10.1084/jem.187.2.237
10.1084/jem.172.6.1861
10.1038/364645a0
10.4049/jimmunol.146.6.1722
10.1016/S0021-9258(19)47397-3
10.1084/jem.177.4.925
10.1002/eji.1830260517
10.1074/jbc.271.22.12852
ContentType Journal Article
Copyright Copyright 1993-1999 The National Academy of Sciences of the United States of America
Copyright © 1999, The National Academy of Sciences 1999
Copyright_xml – notice: Copyright 1993-1999 The National Academy of Sciences of the United States of America
– notice: Copyright © 1999, The National Academy of Sciences 1999
DBID AAYXX
CITATION
7T5
7TM
H94
5PM
DOI 10.1073/pnas.96.4.1234
DatabaseName CrossRef
Immunology Abstracts
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
DatabaseTitleList
AIDS and Cancer Research Abstracts


CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
EISSN 1091-6490
EndPage 1239
ExternalDocumentID PMC15446
10_1073_pnas_96_4_1234
96_4_1234
47185
GroupedDBID ---
-DZ
-~X
.55
.GJ
0R~
123
29P
2AX
2FS
2WC
3O-
4.4
53G
5RE
5VS
85S
AACGO
AAFWJ
AANCE
AAYJJ
ABBHK
ABOCM
ABPLY
ABPPZ
ABTLG
ABXSQ
ABZEH
ACGOD
ACHIC
ACIWK
ACNCT
ACPRK
ADQXQ
ADULT
ADXHL
AENEX
AEUPB
AEXZC
AFFNX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AQVQM
AS~
BKOMP
CS3
D0L
DCCCD
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HGD
HH5
HQ3
HTVGU
HYE
IPSME
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
KQ8
L7B
LU7
MVM
N9A
NEJ
NHB
N~3
O9-
OK1
P-O
PNE
PQQKQ
R.V
RHI
RNA
RNS
RPM
RXW
SA0
SJN
TAE
TN5
UKR
VOH
W8F
WH7
WHG
WOQ
WOW
X7M
XSW
Y6R
YBH
YKV
YSK
ZCA
ZCG
~02
~KM
-
02
08R
0R
1AW
55
AAPBV
ABFLS
ABPTK
ADACO
ADZLD
AFDAS
AJYGW
AS
ASUFR
DNJUQ
DOOOF
DWIUU
DZ
F20
GJ
JSODD
KM
OHM
PQEST
RHF
VQA
X
XFK
XHC
ZA5
AAYXX
CITATION
7T5
7TM
H94
5PM
ID FETCH-LOGICAL-c393t-d5904c3a1790c60fcc90932d7d1fe7605e7131bbe2ce1e7c64ef2d263d5e326c3
ISSN 0027-8424
IngestDate Thu Aug 21 13:21:52 EDT 2025
Fri Jul 11 09:44:16 EDT 2025
Thu Apr 24 23:00:32 EDT 2025
Tue Jul 01 00:46:48 EDT 2025
Thu May 30 08:52:18 EDT 2019
Wed Nov 11 00:29:57 EST 2020
Thu May 29 08:40:54 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c393t-d5904c3a1790c60fcc90932d7d1fe7605e7131bbe2ce1e7c64ef2d263d5e326c3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
To whom reprint requests should be addressed at: Department of Oncology The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. e-mail: jinoue@ims.u-tokyo.ac.jp.
Communicated by Inder M. Verma, The Salk Institute for Biological Studies, San Diego, CA
PMID 9990007
PQID 17166314
PQPubID 23462
PageCount 6
ParticipantIDs pnas_primary_96_4_1234
proquest_miscellaneous_17166314
jstor_primary_47185
pubmedcentral_primary_oai_pubmedcentral_nih_gov_15446
crossref_citationtrail_10_1073_pnas_96_4_1234
pnas_primary_96_4_1234_fulltext
crossref_primary_10_1073_pnas_96_4_1234
ProviderPackageCode RNA
PNE
CITATION
AAYXX
PublicationCentury 1900
PublicationDate 19990216
1999-02-16
PublicationDateYYYYMMDD 1999-02-16
PublicationDate_xml – month: 2
  year: 1999
  text: 19990216
  day: 16
PublicationDecade 1990
PublicationTitle Proceedings of the National Academy of Sciences - PNAS
PublicationYear 1999
Publisher National Academy of Sciences of the United States of America
National Acad Sciences
The National Academy of Sciences
Publisher_xml – name: National Academy of Sciences of the United States of America
– name: National Acad Sciences
– name: The National Academy of Sciences
References Ishida T (e_1_3_3_20_2) 1995; 155
Bjorck P (e_1_3_3_16_2) 1993; 78
Torres R M (e_1_3_3_30_2) 1992; 148
Berberich I (e_1_3_3_14_2) 1994; 153
e_1_3_3_19_2
e_1_3_3_38_2
e_1_3_3_18_2
e_1_3_3_39_2
e_1_3_3_13_2
e_1_3_3_36_2
e_1_3_3_12_2
e_1_3_3_37_2
e_1_3_3_15_2
e_1_3_3_34_2
e_1_3_3_35_2
e_1_3_3_32_2
e_1_3_3_33_2
e_1_3_3_11_2
e_1_3_3_10_2
e_1_3_3_31_2
e_1_3_3_40_2
Barrett T B (e_1_3_3_17_2) 1991; 146
e_1_3_3_6_2
e_1_3_3_5_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_28_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_24_2
e_1_3_3_23_2
e_1_3_3_26_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_43_2
e_1_3_3_1_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_41_2
e_1_3_3_3_2
e_1_3_3_21_2
e_1_3_3_42_2
References_xml – ident: e_1_3_3_29_2
  doi: 10.1002/eji.1830200819
– ident: e_1_3_3_24_2
  doi: 10.1016/0092-8674(95)90489-1
– ident: e_1_3_3_36_2
  doi: 10.1128/MCB.16.12.7098
– ident: e_1_3_3_1_2
  doi: 10.1126/science.8171316
– volume: 78
  start-page: 218
  year: 1993
  ident: e_1_3_3_16_2
  publication-title: Immunology
– ident: e_1_3_3_28_2
  doi: 10.1101/gad.10.8.963
– ident: e_1_3_3_31_2
  doi: 10.1038/385540a0
– ident: e_1_3_3_39_2
  doi: 10.1038/383443a0
– ident: e_1_3_3_41_2
  doi: 10.1073/pnas.95.7.3537
– ident: e_1_3_3_26_2
  doi: 10.1073/pnas.93.18.9437
– ident: e_1_3_3_34_2
  doi: 10.1016/0092-8674(84)90472-0
– ident: e_1_3_3_43_2
  doi: 10.1111/j.1600-065X.1994.tb00845.x
– ident: e_1_3_3_25_2
  doi: 10.1016/0014-5793(94)01406-Q
– ident: e_1_3_3_18_2
  doi: 10.1084/jem.182.5.1557
– volume: 155
  start-page: 5527
  year: 1995
  ident: e_1_3_3_20_2
  publication-title: J Immunol
  doi: 10.4049/jimmunol.155.12.5527
– volume: 148
  start-page: 620
  year: 1992
  ident: e_1_3_3_30_2
  publication-title: J Immunol
  doi: 10.4049/jimmunol.148.2.620
– ident: e_1_3_3_38_2
  doi: 10.1073/pnas.93.18.9699
– ident: e_1_3_3_9_2
  doi: 10.1038/30996
– ident: e_1_3_3_10_2
  doi: 10.1038/31002
– ident: e_1_3_3_3_2
  doi: 10.1084/jem.169.6.2043
– ident: e_1_3_3_4_2
  doi: 10.1038/357080a0
– volume: 153
  start-page: 4357
  year: 1994
  ident: e_1_3_3_14_2
  publication-title: J Immunol
  doi: 10.4049/jimmunol.153.10.4357
– ident: e_1_3_3_13_2
  doi: 10.1084/jem.179.2.673
– ident: e_1_3_3_27_2
  doi: 10.1074/jbc.271.46.28745
– ident: e_1_3_3_12_2
  doi: 10.1084/jem.179.6.1923
– ident: e_1_3_3_23_2
  doi: 10.1126/science.7533327
– ident: e_1_3_3_2_2
  doi: 10.1002/j.1460-2075.1989.tb03521.x
– ident: e_1_3_3_22_2
  doi: 10.1016/S0021-9258(18)43772-6
– ident: e_1_3_3_35_2
  doi: 10.1021/bi981067q
– ident: e_1_3_3_40_2
  doi: 10.1073/pnas.94.18.9792
– ident: e_1_3_3_7_2
  doi: 10.1002/eji.1830221112
– ident: e_1_3_3_33_2
  doi: 10.1073/pnas.89.12.5206
– ident: e_1_3_3_32_2
  doi: 10.1073/pnas.82.2.488
– ident: e_1_3_3_8_2
  doi: 10.1038/30989
– ident: e_1_3_3_21_2
  doi: 10.1016/0092-8674(94)90532-0
– ident: e_1_3_3_42_2
  doi: 10.1084/jem.187.2.237
– ident: e_1_3_3_6_2
  doi: 10.1084/jem.172.6.1861
– ident: e_1_3_3_5_2
  doi: 10.1038/364645a0
– volume: 146
  start-page: 1722
  year: 1991
  ident: e_1_3_3_17_2
  publication-title: J Immunol
  doi: 10.4049/jimmunol.146.6.1722
– ident: e_1_3_3_11_2
  doi: 10.1016/S0021-9258(19)47397-3
– ident: e_1_3_3_15_2
  doi: 10.1084/jem.177.4.925
– ident: e_1_3_3_19_2
  doi: 10.1002/eji.1830260517
– ident: e_1_3_3_37_2
  doi: 10.1074/jbc.271.22.12852
SSID ssj0009580
Score 1.9085736
Snippet CD40 signaling modulates the immune response at least in part by activation of nuclear factor κ B (NFκ B). It has been shown that two distinct domains in the...
CD40 signaling modulates the immune response at least in part by activation of nuclear factor κB (NFκB). It has been shown that two distinct domains in the...
CD40 signaling modulates the immune response at least in part by activation of nuclear factor Kappa B (NF Kappa B). It has been shown that two distinct domains...
CD40 signaling modulates the immune response at least in part by activation of nuclear factor κB (NFκB). It has been shown that two distinct domains in the...
SourceID pubmedcentral
proquest
crossref
pnas
jstor
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 1234
SubjectTerms Antibodies
B lymphocytes
Biochemistry
Biological Sciences
Cell extracts
Gels
Genetic mutation
Physiological regulation
Plasmids
Proteins
T lymphocytes
Title Two Differently Regulated Nuclear Factor κ B Activation Pathways Triggered by the Cytoplasmic Tail of CD40
URI https://www.jstor.org/stable/47185
http://www.pnas.org/content/96/4/1234.abstract
https://www.proquest.com/docview/17166314
https://pubmed.ncbi.nlm.nih.gov/PMC15446
Volume 96
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbpswFLayTpN6M63dqmW_vli1TREsgIFwmWSdqkmNcpFK3RUyxjRZGogSUJU-2h5ib7H32DE2BqRs2nqDEjAQOF_Oj33OdxB6RynpDyIXtF-S9CFAsSwj4BYxEj9iNuVeP6GiUPhi4p1fkq9X7lWn86uRtVTkkcnu9taV3EeqsA_kKqpk_0Oy-qKwAz6DfGELEobtv8n4NtMdTvKbXW8jG8uXK_pM9INQ7XR6p-Oz09FwVDJnyDlYQag6v6W7bS-H-PxadOwsPVFADdvl2RqcapE1L_JLy4yNz5LuqPJjp9rubassg0k1rTisi1SU5tj2jN50Urc8nm2LJQWMZHLlKCoyrfdBvexEfye1prSYL5b64PCuWFE5jb0sNtqefKMrfbEZjcXZ9VyG5D-wDVlqaVbVcH_7sU1FbgO8iCy_NrnU3eD6GB6R3Ucr5S7b5SoQk4amBotNGlYfvgZ7LQqoQNEGOaVbM_BMYlbnNeC1XpX4gucRHldtWHW64_RiLEiPvAfooQ3RjF3ajyY39EBWSqlnqrhFfedT-76H6JG6ScuLkom0gp0XRrcipXaeb8Nxmj1Bj1XEg4cSvkeow9NjdFS9bPxBEZ9_fIq-A55xA89Y4xkrPGOJZ_zzxwjXWMYVlrHGMo52GECJG1jGAss4S7DA8jN0-eVsNj43VC8QgzmBkxuxG_QJc6gglGOgQRgL-hB6xH5sJdyHmJz7lmNFEbcZt7jPPMITO7Y9J3Y5RCjMOUEHaZby5wgPLCf2Ek4GzLFIEpHI5nBeEPGBb8XU6XeRUb3bkCmifNGv5SYsEzZ8JxTvOQy8kIRCKl30Xo9fS4qYP448LkWlhwnP0O2ik3JYtbMx_O3-A2GiEsPECCXsEMyCWOujKc-KbShYsDx4vi5yWxjQFxO08u0j6WJe0suXUH1xz_NeosP6j_0KHeSbgr8Gtz2P3pSg_w2YEvag
linkProvider ABC ChemistRy
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Two+differently+regulated+nuclear+factor+%CE%BAB+activation+pathways+triggered+by+the+cytoplasmic+tail+of+CD40&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Tsukamoto%2C+Nobuo&rft.au=Kobayashi%2C+Norihiko&rft.au=Azuma%2C+Sakura&rft.au=Yamamoto%2C+Tadashi&rft.date=1999-02-16&rft.pub=The+National+Academy+of+Sciences&rft.issn=0027-8424&rft.eissn=1091-6490&rft.volume=96&rft.issue=4&rft.spage=1234&rft.epage=1239&rft_id=info:doi/10.1073%2Fpnas.96.4.1234&rft_id=info%3Apmid%2F9990007&rft.externalDocID=PMC15446
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F96%2F4.cover.gif
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F96%2F4.cover.gif